agilon health (NYSE:AGL) Stock Rating Upgraded by Citigroup

agilon health (NYSE:AGL) was upgraded by stock analysts at Citigroup from a “sell” rating to a “neutral” rating in a note issued to investors on Friday,Briefing.com Automated Import reports. The brokerage presently has a $2.25 price target on the stock, up from their previous price target of $1.75. Citigroup’s target price suggests a potential upside of 1.81% from the stock’s previous close.

Several other equities research analysts also recently issued reports on AGL. Stifel Nicolaus decreased their price target on agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a report on Tuesday, November 12th. William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. TD Cowen cut their target price on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Barclays dropped their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a report on Monday, November 11th. Finally, Macquarie began coverage on agilon health in a research note on Monday, December 16th. They issued a “neutral” rating and a $3.00 price objective for the company. Two research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $3.98.

agilon health Stock Performance

Shares of AGL opened at $2.21 on Friday. agilon health has a one year low of $1.50 and a one year high of $9.30. The company has a market cap of $910.56 million, a PE ratio of -2.35 and a beta of 0.53. The stock has a 50-day moving average of $2.07 and a 200-day moving average of $3.79. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

agilon health (NYSE:AGL) last issued its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The firm had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same quarter in the prior year, the business earned ($0.06) earnings per share. On average, equities research analysts predict that agilon health will post -0.52 EPS for the current fiscal year.

Insiders Place Their Bets

In other agilon health news, Director Karen Mcloughlin purchased 25,000 shares of the company’s stock in a transaction dated Friday, December 13th. The stock was purchased at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the transaction, the director now owns 73,166 shares in the company, valued at $160,965.20. The trade was a 51.90 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Diana Mckenzie acquired 12,500 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The stock was bought at an average price of $2.28 per share, for a total transaction of $28,500.00. Following the completion of the transaction, the director now owns 51,319 shares of the company’s stock, valued at $117,007.32. The trade was a 32.20 % increase in their position. The disclosure for this purchase can be found here. Insiders have bought 90,000 shares of company stock worth $198,100 in the last three months. 3.20% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On agilon health

Hedge funds have recently made changes to their positions in the business. Principal Financial Group Inc. raised its position in agilon health by 42.4% in the 2nd quarter. Principal Financial Group Inc. now owns 41,675 shares of the company’s stock worth $273,000 after purchasing an additional 12,411 shares during the period. Rhumbline Advisers increased its holdings in shares of agilon health by 24.3% in the second quarter. Rhumbline Advisers now owns 433,019 shares of the company’s stock worth $2,832,000 after buying an additional 84,573 shares during the period. Arizona State Retirement System lifted its stake in shares of agilon health by 2.5% in the 2nd quarter. Arizona State Retirement System now owns 85,989 shares of the company’s stock valued at $562,000 after acquiring an additional 2,070 shares during the last quarter. Wedbush Securities Inc. boosted its holdings in agilon health by 72.6% during the 2nd quarter. Wedbush Securities Inc. now owns 20,710 shares of the company’s stock valued at $135,000 after acquiring an additional 8,710 shares during the period. Finally, AGF Management Ltd. grew its position in agilon health by 3.3% during the 2nd quarter. AGF Management Ltd. now owns 381,915 shares of the company’s stock worth $2,498,000 after acquiring an additional 12,063 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.